Pre-market hot trades in US stocks: Adaptimmune Therap pre-market down 10.50%; Annovis Bio pre-market down 9.09%

Popular Pre-Market Trades in US Stocks Adaptimmune Therap pre-market down 10.50%. Based on recent key news: On October 9, Adaptimmune submitted an initial beneficial ownership statement showing Chief Financial Officer Christopher James Hill as the beneficial owner. This news may raise market concerns about the company's internal governance structure, leading to stock price fluctuations. On October 9, analyst Michael Schmidt downgraded the rating of ADAP stock from Buy to Hold, while Barclays analyst Peter Lawson reiterated a Sell rating on ADAP. The negative evaluations from analysts intensified market concerns about the company's financial performance, further pressuring the stock price. On October 9, AI analysis tools gave ADAP stock a Neutral rating with a score of 44/100, reflecting the company's weak financial performance, including declining revenue, ongoing losses, and a fragile balance sheet, all of which impacted the stock price. The market is skeptical about the company's financial performance. Annovis Bio pre-market down 9.09%. Based on recent important news: On October 9, Annovis Bio announced that its drug Buntanetap showed new biomarker data in Alzheimer's patients, supporting its potential as a disease-modifying treatment. This news attracted market attention but failed to prevent the stock price from falling. Data source: GlobeNewswire. The biotechnology industry is highly volatile and requires caution. Top Gainers in US Pre-Market ESS Tech pre-market up 128.49%. Based on recent key news: On October 9, ESS Tech announced a new 50 MWh long-duration energy storage pilot project with Salt River Project. This collaborative project will be installed at the Copper Crossing Energy and Research Center in Arizona, significantly boosting the company's stock price. On October 9, ESS Tech's stock price had fallen 78.09% over the past year, but the day's news triggered heavy trading, with approximately 78 million shares changing hands, far exceeding the three-month daily average trading volume. On October 9, ESS Tech's press release published via Business Wire emphasized the company's leading position in the long-duration energy storage systems sector. The energy storage industry trend is positive, and trading is active. Safe & Green pre-market up 91.63%. No recent news. Leifras pre-market up 55.63%. Based on recent key news: On October 9, Leifras announced that its American Depositary Shares would begin trading on Nasdaq under the ticker "LFS." This news spurred market interest in the stock, leading to a significant increase in its price Data Source: Press Release On October 9th, Leifras raised $5 million by issuing 1.3 million ADS at an issuance price of $4 per share, which is at the lower end of the expected range. This move has strengthened market confidence in the company's future development. Data Source: Press Release Nasdaq IPO has attracted attention